Clinical trials recruiting for Carcinoma, Non-Small-Cell Lung (NSCLC)
5
Recruiting trials
31
US states with sites
34
Countries
0%
Accept healthy volunteers
Phase breakdown
Phase 2 1Phase 3 2Not applicable 2
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Chemotherapy Regimen 1 | 2 |
| Chemotherapy Regimen 2 | 2 |
| PF-08634404 | 2 |
| Pembrolizumab | 2 |
| Sigvotatug Vedotin | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| California | 3 |
| Illinois | 3 |
| Nebraska | 3 |
| Florida | 2 |
| Minnesota | 2 |
| Mississippi | 2 |
| New York | 2 |
| North Carolina | 2 |
| Ohio | 2 |
| Tennessee | 2 |
| Texas | 2 |
| Washington | 2 |
Top cities
Hinsdale, Illinois 3Lincoln, Nebraska 3New Lenox, Illinois 3Burnsville, Minnesota 2Canton, Ohio 2Cleveland, Ohio 2Coon Rapids, Minnesota 2Edina, Minnesota 2El Paso, Texas 2Houston, Texas 2
Self-screener
Recruiting trials
- Prospective Cohort Study Evaluating 18FDG PET-CT for the Early Prediction of the Efficacy of Immunotherapy Associated or Not With Chemotherapy in Patients With Locally Advanced or Metastatic Non-Small Cell Broncho-Pulmonary Carcinoma
- Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
- Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC
- This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
- Vortioxetine for Cognitive Function in ALK-positive NSCLC Treated With Lorlatinib
Related conditions
Trials recruiting for Carcinoma, Non-Small-Cell Lung (NSCLC) often also study these conditions. Each links to its own recruiting-trial list.
Lung cancer 2180Non-small cell lung cancer 507Non-Small-Cell Lung 6Metastatic Non Small Cell Lung Cancer 18Lung Neoplasms 33Lung Disease 3Lung Adenocarcinoma 31Depression 1463Cognitive Dysfunction 32Carcinoma 7
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Carcinoma, Non-Small-Cell Lung (NSCLC) trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.